Cargando…

Evaluation of novel highly specific antibodies to cancer testis antigen Centrin‐1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) accounts for >90% of pancreatic malignancies, and has median survival of <6 months. There is an urgent need for diagnostic and therapeutic options for PDAC. Centrin1 (CETN1) is a novel member of Cancer/Testis Antigens, with a 25‐fold increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Rubin, Allen, Kevin J. H., Malo, Mackenzie E., Helal, Muath, Jiang, Zewei, Smart, Karishma, Buhl, Susan V., Rickles, David, Bryan, Ruth A., Dadachova, Ekaterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718527/ https://www.ncbi.nlm.nih.gov/pubmed/31309741 http://dx.doi.org/10.1002/cam4.2379

Ejemplares similares

Mechanistic Insights into Synergy between Melanin-Targeting Radioimmunotherapy and Immunotherapy in Experimental Melanoma
por: Malo, Mackenzie E., et al.
Publicado: (2020)

Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium
por: Allen, Kevin J. H., et al.
Publicado: (2019)

Evaluating the Combination of Radioimmunotherapy and Immunotherapy in a Melanoma Mouse Model
por: Jiao, R., et al.
Publicado: (2020)

Beta emitters rhenium‐188 and lutetium‐177 are equally effective in radioimmunotherapy of HPV‐positive experimental cervical cancer
por: Phaeton, Rebecca, et al.
Publicado: (2015)

Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody
por: Helal, Muath, et al.
Publicado: (2020)

HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
por: Altunay, Betül, et al.
Publicado: (2020)

Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections
por: Helal, Muath, et al.
Publicado: (2020)

Daratumumab-(225)Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors
por: Dawicki, Wojciech, et al.
Publicado: (2019)

Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections
por: Dadachova, Ekaterina, et al.
Publicado: (2011)

Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy
por: Nosanchuk, J. D., et al.
Publicado: (2018)

Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma
por: Broqueza, Jaline, et al.
Publicado: (2021)

Targeting Melanin in Melanoma with Radionuclide Therapy
por: Allen, Kevin J. H., et al.
Publicado: (2022)

Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
por: Harris, Matthew, et al.
Publicado: (2011)

Radioimmunotherapy of Fungal Diseases: The Therapeutic Potential of Cytocidal Radiation Delivered by Antibody Targeting Fungal Cell Surface Antigens
por: Nosanchuk, Joshua D., et al.
Publicado: (2012)

Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics
por: Allen, Kevin J. H., et al.
Publicado: (2018)

Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models
por: Broqueza, Jaline, et al.
Publicado: (2021)

Radioimmunotherapy of methicillin-resistant Staphylococcus aureus in planktonic state and biofilms
por: van Dijk, B., et al.
Publicado: (2020)

Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors
por: Karkare, Sharayu, et al.
Publicado: (2019)

Golgi relies on centrin
por: LeBrasseur, Nicole
Publicado: (2005)

TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluorescent staining
por: Shi, Dai, et al.
Publicado: (2019)

Centrin 3 is an inhibitor of centrosomal Mps1 and antagonizes centrin 2 function
por: Sawant, Dwitiya B., et al.
Publicado: (2015)

Trypanosoma brucei centrin5 is enriched in the flagellum and interacts with other centrins in a calcium‐dependent manner
por: Shan, Fangzhen, et al.
Publicado: (2019)

Comprehensive characterization of cancer‐testis genes in testicular germ cell tumor
por: Chang, Yuting, et al.
Publicado: (2019)

Control of Centrin Stability by Aurora A
por: Lukasiewicz, Kara B., et al.
Publicado: (2011)

A Theranostic Approach to Imaging and Treating Melanoma with (203)Pb/(212)Pb-Labeled Antibody Targeting Melanin
por: Jiao, Rubin, et al.
Publicado: (2023)

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
por: Zhang, Yujie, et al.
Publicado: (2019)

Radioimmunoimaging of Liver Metastases with PET Using a (64)Cu-Labeled CEA Antibody in Transgenic Mice
por: Nittka, Stefanie, et al.
Publicado: (2014)

A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging
por: Yamamura, Miyuki, et al.
Publicado: (1996)

Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals
por: Tsukrov, Dina, et al.
Publicado: (2016)

Radioimmunoimaging of (125)I-labeled anti-CD93 monoclonal antibodies in a xenograft model of non-small cell lung cancer
por: Liu, Weiwei, et al.
Publicado: (2019)

A Role for Centrin 3 in Centrosome Reproduction
por: Middendorp, Sandrine, et al.
Publicado: (2000)

Cancer‐testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma
por: Xie, Kaipeng, et al.
Publicado: (2017)

Radioimmunotherapy in colorectal cancer treatment: present and future
por: Shi, Jingyi, et al.
Publicado: (2023)

Transcriptomic and genomic changes associated with radioadaptation in Exophiala dermatitidis
por: Malo, Mackenzie E., et al.
Publicado: (2020)

Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activation
por: Zhou, Han, et al.
Publicado: (2023)

Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein
por: Harris, M, et al.
Publicado: (2013)

Long-term Testis Cancer Survivors in Canada—Mortality Risks in a Large Population-based Cohort
por: Lavi, Arnon, et al.
Publicado: (2020)

Click-to-Release: Cleavable Radioimmunoimaging with [(89)Zr]Zr-DFO-Trans-Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio
por: Vlastara, Maria, et al.
Publicado: (2023)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
por: Sabanathan, Dhanusha, et al.
Publicado: (2021)

Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer
por: Hecht, Markus, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lu0u4p7vgl4jujbm413bh621m5